about
Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems.Validation of a high-performance liquid chromatography method for the determination of (-)-alpha-bisabolol from particulate systems.Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.Natural extracts into chitosan nanocarriers for rosmarinic acid drug delivery.Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsChitosan formulations as carriers for therapeutic proteins.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.Models to predict intestinal absorption of therapeutic peptides and proteins.Cell-based in vitro models for predicting drug permeability.Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.Quality by design: discussing and assessing the solid dispersions risk.Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy.Sustained drug release by contact lenses for glaucoma treatment-a review.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Chitosan-based nanoparticles for rosmarinic acid ocular delivery--In vitro tests.Influence of glioma cells on a new co-culture in vitro blood-brain barrier model for characterization and validation of permeability.Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin.Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages.Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition.Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation.Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets.Oral insulin delivery by means of solid lipid nanoparticles.Naproxen availability from variable-dose and weight sustained-release tablets.Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes.Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique.
P50
Q30979533-7F5A7DD6-C338-4F69-867A-BF14D9C81614Q33230716-03FFE7BA-D50A-4F3F-99C2-679A04620476Q33428087-1BA08A9E-2B18-4C0B-8693-5A03684A3FD0Q34293616-FA31E2C1-71D4-48F2-B9E1-D16D546F3600Q35122206-6ABA24A1-03FC-4A4E-848A-4C3CF1CA3797Q35502502-6B72FBBF-B9DB-4576-B076-4E8356D2A1DDQ35829126-F53D7E70-4771-47D8-9D15-313359B15DDDQ37003811-5841E9B6-2F79-4352-8788-4F7B942034E5Q37013417-8B0C4306-C754-4277-A184-EF6C0C15C705Q37811020-3CCD4C60-7453-47FE-A7A5-4D2D6333DF88Q37823598-C788D6CE-77A6-49A1-BA92-79C12D968594Q37935826-41233B48-66FF-4B93-A511-49F04C3C2D76Q37994260-130938A1-0584-46AA-AAA9-A38492CB45F4Q38029748-D8ADF590-2E76-4B48-B156-34EC4A81B0CFQ38128069-4DE94427-2780-43FE-8819-652B0812E2C2Q38187202-4F8F19FA-AC9B-455C-829E-3338528CF753Q38215918-994B35C6-24CA-42E7-BD71-A978AB9B1223Q38330865-18CC7804-EF26-4D39-BE13-CE675AC3CAF9Q38587566-B8C97D23-C649-4F35-9AF6-9BC612140CECQ38813783-7138AAD8-9E92-4CD8-A86A-BADDC7E4062DQ38874030-5FA2934C-E935-4CFF-B0BD-9F891F3E09FDQ38998656-927C0B14-1B98-4A9E-8537-759BA3357951Q39102128-22845B08-B2C6-4722-A0BA-CE898F1C4DFCQ39125304-C3FB60C5-E939-4937-9CBD-A8070A043F5DQ39263714-DB8C4FE4-C95C-42D9-B0E4-28C2B602C90DQ39355306-A86AAA33-9257-40FE-8A6B-4F8E04405FACQ39371382-E2BAB2A8-B297-4C43-AFB8-6CD3E2AAB190Q39470095-FEE98882-2BF9-46A6-912A-6B7E003F8AEFQ39664447-659CE0AF-801A-467A-8E7B-64A9CB365AE8Q39795941-422F1FCC-A447-42E7-A9A5-F390504E13C9Q41987261-7CC9BAA9-B334-4787-BD57-C3E03A31D11DQ42563860-342250F4-CF67-4294-9646-155D654E4096Q43135649-33155D0A-27AA-4516-B92B-E2CE95A7AFB5Q43567391-FA7CDFB7-EC60-454E-B3F6-ED3B87E83576Q44545803-CF862D7A-E446-4E3A-B67B-445AA416D0F2Q44638902-1315E8FD-60BC-4171-8C96-D051F472C893Q44735346-CF7C8E3B-394E-4053-B219-233AE008043AQ46060271-9E0F3027-40C3-4420-80B3-57CD7E80BEDBQ46374135-206B815F-1D03-4BCD-BAC4-72014EBF7939Q46458241-40ABCE66-8C68-4079-8231-1E27D2E338C5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Domingos Ferreira
@ast
Domingos Ferreira
@en
Domingos Ferreira
@es
Domingos Ferreira
@nl
Domingos Ferreira
@sl
type
label
Domingos Ferreira
@ast
Domingos Ferreira
@en
Domingos Ferreira
@es
Domingos Ferreira
@nl
Domingos Ferreira
@sl
prefLabel
Domingos Ferreira
@ast
Domingos Ferreira
@en
Domingos Ferreira
@es
Domingos Ferreira
@nl
Domingos Ferreira
@sl
P214
P1005
P1053
M-7978-2017
P106
P1153
56871285000
56962785200
P21
P213
0000 0000 7002 6514
P214
P31
P3829
P496
0000-0001-6200-7169